Biologically active ligands for yersinia outer protein H (YopH): feature based pharmacophore screening, docking and

Thangaraju Tamilvanan, Waheeta Hopper1

  • 1Department of Bioinformatics, School of Bioengineering, Faculty of Engineering & Technology, SRM University, Kattankulathur-603203, Tamil Nadu, India. hod.bioinfo@ktr.srmuniv.ac.in.

Insights

Researchers developed a 3D pharmacophore model to identify new Yersinia pestis YopH inhibitors. This model aids in designing potential antitoxins by highlighting key structural features for YopH inhibition.

Area of Science:

  • Microbiology
  • Structural Biology
  • Drug Discovery

Background:

  • Yersinia pestis causes plague by spreading through the lymphatic system and bloodstream.
  • Yersinia outer protein H (YopH) is a key effector protein that impairs immune cells like lymphocytes and macrophages.
  • YopH functions by dephosphorylating crucial tyrosine kinases and signal transduction molecules, leading to immune paralysis.

Purpose of the Study:

  • To create a three-dimensional (3D) pharmacophore model for Yersinia outer protein H (YopH) inhibitors.
  • To identify essential structural features contributing to YopH inhibitory activity.
  • To facilitate the design of novel antitoxin compounds against Yersinia pestis.

Main Methods:

  • A ligand-based pharmacophore study was conducted using 60 biologically active YopH inhibitors.
  • Database screening identified novel compounds based on the pharmacophore model.
  • In silico methods including docking, ADME property prediction, binding energy calculation, and molecular dynamics simulations (RMSD, RMSF) were employed for validation.

Main Results:

  • The pharmacophore model revealed that two acceptor, one hydrophobic, and two aromatic features are critical for YopH inhibition.
  • Screening and subsequent analyses identified four potential YopH inhibitors: ASN03270114, Mol_252138, Mol_31073, and ZINC04237078.
  • Molecular dynamics simulations confirmed the stability and binding characteristics of the identified compounds.

Conclusions:

  • The developed 3D pharmacophore model effectively captures essential features for YopH inhibition.
  • The identified compounds show promise as potential inhibitors of Yersinia pestis YopH.
  • This study provides a foundation for designing new antitoxin therapies against plague.